bioRxivBiochemistry
Evidence for hyper-reductive redox in a subset of heart failure patients
T. Sairam, A. N. Patel, M. Subrahmanian, R. Gopalan, S. M. Pogwizd, S. Ramalingam, S. Ramalingam, R. Namakkal-Soorappan
Abstract
BackgroundOxidative stress has been linked to heart failure (HF) in humans. Antioxidant-based treatments are often ineffective. Therefore, we hypothesize that some of the HF patients might have a reductive stress (RS) condition. Investigating RS-related mechanisms will aid in personalized optimization of redox homeostasis for better outcomes among HF patients.\n\nMethodsBlood samples were collected from HF patients (n=54) and healthy controls (n=42) and serum was immediately preserved in -80{degrees}C for redox analysis. Malondialdehyde (MDA; lipid peroxidation) levels by HPLC, reduced glutathione (GSH) and its redox ratio (GSH/GSSG) using enzymatic-recycling assay in the serum of HF patients were measured. Further, the kinetics of key enzymatic-antioxidant enzymes was analyzed by UV-Vis spectrophotometry. Non-invasive echocardiography was used to relate circulating redox status with cardiac function and remodeling.\n\nResultsThe circulatory redox state (GSH/MDA ratio) was used to stratify the HF patients into normal redox (NR), hyper-oxidative (HO), and hyper-reductive (HR) groups. While the majority of the HF patients exhibited the HO (42%), 41% of them had a normal redox (NR) state. Surprisingly, a subset of HF patients (17%) belonged to the hyper-reductive group, suggesting a strong implication for RS in the progression of HF. In HF patients, SOD, GPx and catalase were significantly increased while GR activity was significantly reduced relative to healthy controls. Furthermore, echocardiography analyses revealed that 55% of HO patients had higher systolic dysfunction while 75% of the hyper-reductive patients had higher diastolic dysfunction.\n\nConclusionThese results suggest that RS may be associated with HF pathogenesis for a subset of cardiac patients. Thus, stratification of HF patients based on their circulating redox status may serve as a useful prognostic tool to guide clinicians designing personalized antioxidant therapies.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epigenetic modulators link mitochondrial redox homeostasis to cardiac function
Zaher Elbeck, Mohammad Bakhtiar Hossain, … Christer Betsholtz·Nature CommunicationsPeer-reviewed·Mar 20, 2024
- Reversible thiol oxidation increases mitochondrial electron transport complex enzyme activity but not respiration in cardiomyocytes from patients with end-stage heart failure
R. A. Kumar, T. Thome, … L. F. Ferreira·bioRxiv·May 27, 2022
- Loss of MGST1 during fibroblast differentiation enhances vulnerability to oxidative stress in human heart failure
Mohamad Youness, Onne A. H. O. Ronda, … H. Llewelyn Roderick·bioRxiv·Nov 14, 2025
- Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon Agonism
Jake E. Doiron, Mahmoud H. Elbatreek, … David J. Lefer·JACC Basic to Translational SciencePeer-reviewed·Aug 6, 2025
- Endothelial Function: A Novel Marker to Evaluate the Prognosis of Heart Failure with Reduced Ejection Fraction
Salma Charfeddine, Mohamed Ali Hbaieb, … Leila Abid·American Journal of Physiology-Heart and Circulatory PhysiologyPeer-reviewed·Jan 17, 2026
- Restore mitophagy is essential to prevent cardiac oxidative stress during hypertrophy
V. Peugnet, M. Chwastyniak, … E. Dubois-Deruy·bioRxiv·Jan 12, 2021